Finally, lncRNA DANCR showed the ability to support EMT, cancer stemness, and inflammation in BC cells in vitro by promoting the binding of EZH2 to the SOCS3 promoter, thereby inhibiting its expression [253]. This evidence concerns the gene SOCS3 and breast cancer.